Protagonist Therapeutics Inc (PTGX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$8.87B
EV to revenue ratio (TTM)
14.06
EV to ebitda
24
Financial Performance
Revenue (TTM)
$0.55B
Gross profit (TTM)
$0.55B
EBITDA
$0.32B
Profitability
Operating margin (TTM)
79.60%
Profit margin
62.00%
Return on assets (TTM)
21.80%
Return on equity (TTM)
39.60%
Per Share Metrics
Revenue per share (TTM)
$8.44
EPS
$4.73
Diluted EPS (TTM)
$4.73
Book value
$16.64
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
28.73
Trailing P/E
28.73
Forward P/E
36.90
PEG ratio
0
Price to sales ratio (TTM)
16.08
Price to book ratio (TTM)
10.39
Growth
Quarterly earnings growth (YoY)
5,724.00%
Quarterly revenue growth (YoY)
351.30%
Analyst Sentiment
Strong buy
3
Buy
11
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.22